SEC Filings | Vera Therapeutics

Filing date	Form	Description	View
January 10, 2022	UPLOAD	UPLOAD	0000000000-22-000262.pdf 0000000000-22-000262.rtf View HTML
January 24, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-22-006714.pdf 0001104659-22-006714.rtf 0001104659-22-006714.xls View HTML
February 7, 2022	S-1	Registration statement for face-amount certificate companies	0001193125-22-029746.pdf 0001193125-22-029746.rtf 0001193125-22-029746.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 7, 2022	CORRESP	CORRESP	0001193125-22-029843.pdf 0001193125-22-029843.rtf 0001193125-22-029843.xls View HTML
February 7, 2022	CORRESP	CORRESP	0001193125-22-029855.pdf 0001193125-22-029855.rtf 0001193125-22-029855.xls View HTML
February 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0000315066-22-001204.pdf 0000315066-22-001204.rtf View HTML
February 9, 2022	EFFECT	EFFECT	9999999995-22-000386.pdf 9999999995-22-000386.rtf 9999999995-22-000386.xls View HTML
February 10, 2022	S-1MEF	Registration of up to an additional 20% of securities for any offering registered on an S-1	0001193125-22-033630.pdf 0001193125-22-033630.rtf 0001193125-22-033630.xls View HTML
February 11, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-22-020616.pdf 0001104659-22-020616.rtf 0001104659-22-020616.xls View HTML
February 11, 2022	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	0001193125-22-037414.pdf 0001193125-22-037414.rtf 0001193125-22-037414.xls View HTML

Data provided by Kaleidoscope.